EUROPEAN VACCINE INITIATIVE EWIV - 
Ranking results:
Past rankings:
| 2020 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2019 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
Ranking timeline:
Project Participation Performance(2019-01-01 - 2025-12-31 ):
Total Project Funding:
Funding per Partner:
Projects:
Leadership:
Total number of projects: 5
As coordinator: 3
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 1.5*
Summary:
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2022 | 9.999.995 | 20.998.624 | 2.021.468 | 1 | 1 | |
| 2021 | 6.500.000 | 0 | 1.088.600 | 1 | ||
| 2019 | 8.603.990 | 917.338 | 497.130 | 1 | 1 | |
Networking:
Partners:
Constancy:
Total number of partners: 193
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 193
Frequent / Rare Partner Ratio: 0
Project overview:
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2022-06-01 | Advancing The Clinical Development Of Placental Malaria Vaccines In The Context Of Capacity Building and Use Of Digital Health Technologies | ADVANCE-VAC4PM | coordinator | 9.999.995 | 10 |
| 2022-02-01 | Integrated Services for Infectious Disease Outbreak Research | ISIDORe | participant | 20.998.624 | 154 |
| 2021-11-01 | Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance | PrIMAVeRa | coordinator | 6.500.000 | 19 |
| 2019-09-01 | Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea | SHIGETECVAX | coordinator | 8.603.990 | 5 |
| 2019-01-01 | Strengthening international R&I cooperations between China and the EU | SENET | participant | 917.338 | 10 |